Skip to content

Utah Medical Products UTMD Q4 2024 Annual earnings

Reported March 26, 2025

Revenue$9.2M
EPS$0.86

Next report

Oct 22, 2026 (in 3 months)

Financials

Q4 2024

Income statement

See full
Revenue$9.2M-25.8%
Gross profit$5.3M-25.0%
Operating income$2.9M-25.7%
Net income$2.9M-32.3%
EPS (diluted)$0.86-27.1%

Balance sheet

See full
Cash & equivalents$83.0M-10.7%
Total debt$564.0K+64.9%
Total equity$117.4M-8.5%
Total assets$122.5M-9.5%

Cash flow

See full
Operating cash flow$2.9M-44.9%
CapEx$9.0K-90.0%
Free cash flow$2.9M-44.1%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$208.48M-31.8%
Enterprise value$126.07M-40.8%
P/E15×-3.3×
P/S5.1×-1.0×

Profitability

See full
Gross margin59%-0.8pp
Operating margin33.2%-0.2pp
Net margin33.9%+0.8pp
FCF margin35.7%-7.4pp

Returns & leverage

See full
Return on equity11.3%-2.4pp
Debt / equity0.0×
Current ratio25.6×+3.1×

Segments

By product

See full
Gynecology Electrosurgery Urology$16.1M-7.6%
Blood Pressure Monitoring And Accessories$5.0M-55.4%
Neonatal$3.5M-0.2%
Obstetrics$2.0M-6.4%

By geography

See full
Global$10.2M-18.6%
Ous$4.4M-20.7%

Versus estimates

Ask the moment Utah Medical Products reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Utah Medical Products report Q4 2024 earnings?
Utah Medical Products (UTMD) reported Q4 2024 earnings on March 26, 2025.
What were Utah Medical Products's Q4 2024 revenue and EPS?
Utah Medical Products reported revenue of $9.2M and eps of $0.86 for Q4 2024.
Where can I find Utah Medical Products's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001096906-25-000308) directly on SEC EDGAR. The filing index links above go to sec.gov.